Specialists

Pharmaceutical Group Leaders:

Drew Lowery, Ph.D.
Dr. Lowery has led and worked on projects representing a wide array of technologies, such as single molecule nucleic acid amplification and sequencing, pharmaceutical formulation and dosing, satiety hormones, microfludics integrated systems, and biofuel production, among others. He directs all biological sequence searching efforts and specializes in cost efficient strategies for complicated cases. Dr. Lowery launched the Accelerated Examination Support practice, where his searches have been favorable reviewed by the USPTO, leading to patent granting for his clients. Dr. Lowery holds a Ph.D. in Biochemistry from the Massachusetts Institute of Technology where he studied cancer signaling networks.

Daniel Neuman, Ph.D.
Dr. Neuman has directed numerous FTO, acquisition due diligence, prior art, and IP landscape analysis projects for clients in the Pharmaceutical, Chemical and Biotechnology industries. Dr. Neuman’s expertise spans organometallics, spectroscopy, semiconductors, inorganic materials, sol-gel based sensors, polymer science, pharmaceutical formulations, drug delivery platforms, nanomaterials, and photo-activated materials. Dr. Neuman received a B.A. in Chemistry, cum laude, from Boston University where his research focused on the development of transition metal clusters for hydrocarbon activation. While obtaining his Ph.D. in Chemistry from the University of California, Santa Barbara, Dr. Neuman’s research involved the design of nanoparticle (Quantum Dot) -based materials for sensor and drug activation technologies. As a postdoctoral fellow in the Harvard Medical School at Massachusetts General Hospital, Dr. Neuman led a multi-center research project directed at translating nanoparticle platforms for treatment and imaging of ovarian cancer from bench-to-bedside. While at Harvard Medical School Dr. Neuman was awarded the Ruth L. Kirschstein NRSA Postdoctoral Fellowship by the National Institute of Health. He has also authored a number of publications in top tier chemical journals.

Additional Expertise:

David Adamovich, Ph.D.
Ph.D. in Biological and Biomedical Sciences, Harvard University
Expertise in microbiology, genomics, therapeutic formulations

Anchal Jain, M.S.
M.S. in Chemical Engineering Practice, Massachusetts Institute of Technology
Expertise in pharmaceutical formulation development, new materials

Chie Nakamura, Ph.D.
Ph.D. in Natural Sciences, Freie University
Expertise in drug delivery, material sciences

For inquires contact:

Drew Lowery, Ph.D.
Group Leader - Pharmaceuticals & Biotechnology
Phone: US (1) 617.574.9574
dlowery@globalpriorart.com

Daniel Neuman, Ph.D.
Group Leader - Pharmaceuticals & Chemistry
Phone: US (1) 617.574.9574
dneuman@globalpriorart.com